Envoy Medical, Inc.
COCHNasdaqCIK 1840877HealthcareFiscal year ends Dec 31
Reports and events: 129 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1616:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-110266 |
| 2026-10-0709:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-107434 |
| 2026-08-3116:30 ET | DEF 14A | Proxy statementPeriod 2026-10-12 | 0001213900-26-095756 |
| 2026-08-2717:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-094447 |
| 2026-08-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-087221 |
| 2026-08-1008:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-086974 |
| 2026-06-3016:00 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-073659 |
| 2026-06-2516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-072033 |
| 2026-05-2216:05 ET | 8-K | 3.01 Delisting notice | 0001213900-26-060556 |
| 2026-05-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-058429 |
| 2026-05-1108:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-054209 |
| 2026-05-1108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054185 |
| 2026-04-2116:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-046197 |
| 2026-04-1316:30 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001213900-26-043011 |
| 2026-04-0216:01 ET | DEF 14A | Proxy statementPeriod 2026-05-12 | 0001213900-26-039310 |
| 2026-03-3116:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-037419 |
| 2026-03-2716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-035483 |
| 2026-03-2309:26 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-032683 |
| 2026-02-2709:11 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-021116 |
| 2026-02-1709:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-015955 |
| 2026-02-1317:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-016584 |
| 2026-02-1116:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-014878 |
| 2026-02-1021:55 ET | S-1/A | Registration statement, amended | 0001213900-26-013894 |
| 2026-02-0610:58 ET | S-1/A | Registration statement, amended | 0001213900-26-013098 |
| 2025-12-2916:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-126032 |
| 2025-12-1817:20 ET | S-1 | Registration statement | 0001213900-25-123367 |
| 2025-12-1609:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-121987 |
| 2025-12-0806:09 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-119019 |
| 2025-12-0316:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-117805 |
| 2025-12-0116:31 ET | S-1/A | Registration statement, amended | 0001213900-25-116721 |
| 2025-11-2516:01 ET | 8-K | 3.01 Delisting notice | 0001213900-25-114725 |
| 2025-11-1008:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-107902 |
| 2025-11-1008:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-107898 |
| 2025-10-2809:22 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-102828 |
| 2025-10-1716:05 ET | DEF 14A | Proxy statementPeriod 2025-11-26 | 0001213900-25-099960 |
| 2025-10-1710:59 ET | S-1 | Registration statement | 0001213900-25-099775 |
| 2025-10-0909:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-097600 |
| 2025-10-0710:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-096845 |
| 2025-09-2309:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-090373 |
| 2025-09-1906:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-089225 |
| 2025-09-0917:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-086268 |
| 2025-08-2916:30 ET | 8-K | 3.01 Delisting notice | 0001213900-25-082608 |
| 2025-08-2608:35 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-080530 |
| 2025-07-3108:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-069663 |
| 2025-07-3108:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-069658 |
| 2025-07-2916:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-068760 |
| 2025-07-0216:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-061057 |
| 2025-06-2508:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-057481 |
| 2025-06-0316:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-050758 |
| 2025-05-1908:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-045109 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 08:41 ET. Listed shows no prices and gives no investment advice.